Infinant Health Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 52

Employees

  • Latest Deal Type
  • Series D

  • Latest Deal Amount
  • $65M

  • Investors
  • 18

Infinant Health General Information

Description

Developer of microbiome-based products designed to establish, restore, and maintain a healthy gut microbiome. The company's products focus on solving gut dysbiosis throughout the human life cycle as well as in various animal species, enabling physicians to maintain a healthy gut microbiome in newborn infants with a consumer-directed home-use product, and a hospital-based neonatal ICU product.

Contact Information

Formerly Known As
Evolve BioSystems
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Devices and Supplies
Other Healthcare
Other Pharmaceuticals and Biotechnology
Corporate Office
  • 2121 2nd Street
  • Suite C108
  • Davis, CA 95618
  • United States
+1 (844) 000-0000

Infinant Health Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Infinant Health Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series D) 25-May-2021 $65M 00000 00000 Completed Generating Revenue
6. Debt - PPP 11-Jun-2020 00000 0000 Completed Generating Revenue
5. Later Stage VC (Series C) 13-Jun-2018 0000 0000 00000 Completed Generating Revenue
4. Later Stage VC (Series B) 30-May-2017 0000 0000 0000 Completed Generating Revenue
3. Early Stage VC (Series A) 17-Aug-2015 000 0000 0000 Completed Startup
2. Seed Round 15-Sep-2014 $1M $1M 00.000 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Infinant Health’s complete valuation and funding history, request access »

Infinant Health Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D-2 000,000 00.000000 00.00 000.00 000.00 00 000.00 0.000
Series D-1 0,000,000 00.000000 00.00 000.00 000.00 00 000.00 00.000
Series C 0,000,000 00.000000 00.00 00.0 00.0 00 00.0 00.000
Series B 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A 2,091,709 $0.000100 $0.34 $4.3 $4.3 1x $4.3 10.19%
Seed 725,098 $0.000100 $0.11 $1.32 $1.32 1x $1.32 3.53%
To view Infinant Health’s complete cap table history, request access »

Infinant Health Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of microbiome-based products designed to establish, restore, and maintain a healthy gut microbiome. The compan
Biotechnology
Davis, CA
52 As of 2023
00000
0000 0000-00-00
00000000000 00000

0000é

s nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
00000 00000000 000-0
San Diego, CA
00 As of 0000
000.00
000 0000-00-00
00000000000 000.00

000000

. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut ali
0000000000000
Duarte, CA
000 As of 0000
000.00
000000 - 000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Infinant Health Competitors (6)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Floré Venture Capital-Backed San Diego, CA 00 000.00 00000000000 000.00
Prolacta Bioscience Venture Capital-Backed Duarte, CA 000 000.00 000000 - 000 000.00
BiomX Formerly VC-backed Ness Ziona, Israel 00 000.00 000000000 000.00
Seres Therapeutics Formerly VC-backed Cambridge, MA 000 00000 000000000 00000
Kallyope Venture Capital-Backed New York, NY 000 00000 00000000000 00000
To view Infinant Health’s complete competitors history, request access »

Infinant Health Executive Team (22)

Name Title Board Seat Contact Info
Mike Johnson Chief Executive Officer & Board Member
Mandy Kennedy Chief Marketing Officer
Arlene Fosmer Chief Science Officer
Patrick Cormier Senior Vice President of Finance & Controller
Samara Freeman Ph.D Co-Founder & Executive Director, Regulatory Affairs & Intellectual Property
You’re viewing 5 of 22 executive team members. Get the full list »

Infinant Health Board Members (16)

Name Representing Role Since
Bruce German Ph.D Infinant Health Co-Founder & Board Observer 000 0000
Drew Connor Manna Tree Partners Board Observer 000 0000
Erin VanLanduit Self Board Member 000 0000
Frank Palantoni Self Board Observer 000 0000
Gareth Asten Acre Venture Partners Board Member 000 0000
You’re viewing 5 of 16 board members. Get the full list »

Infinant Health Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Infinant Health Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Cargill Corporation Minority 000 0000 000000 0
iSelect Fund Venture Capital Minority 000 0000 000000 0
Manna Tree Partners PE/Buyout Minority 000 0000 000000 0
Skyviews Life Science Venture Capital Minority 000 0000 000000 0
Spur Capital Partners Fund of Funds Minority 000 0000 000000 0
You’re viewing 5 of 18 investors. Get the full list »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »